Lund­beck out-li­cens­es three can­di­dates to Cam­bridge biotech

Lund­beck is out-li­cens­ing three can­di­dates to Neu­ro3 Ther­a­peu­tics, a two-year-old biotech based in Cam­bridge — and giv­ing it­self an op­tion to li­cense back those rights in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER